Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Edward Myles Insider Profile
4 Followers
Edward Myles, CFO and EVP of Corp. Dev. at Ocata Therapeutics, holds 98.66K shares in Amag Pharmaceuticals (Ticker: AMAG), holds 0.00 shares in Ocata Therapeutics (Ticker: OCAT), holds ― shares in Scholar Rock Holding (Ticker: SRRK).
Edward Myles Ocata Therapeutics (OCAT)CFO and EVP of Corp. Dev.
Ocata Therapeutics (OCAT)
CFO and EVP of Corp. Dev.
Not Ranked
Edward Myles has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Edward Myles does not currently own shares as a corporate insider.
A breakdown of Edward Myles's holdings
Insider Roles
Roles that Edward Myles holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Edward Myles
Edward Myles's Trading History
Ocata Therapeutics
Feb 11, 2016
―
Uninformative Sell
476.00K
$0.00
Amag Pharmaceuticals
Mar 12, 2020
―
Uninformative Buy
―
$1.36M
Scholar Rock Holding
―
CFO
―
―
Pressure Biosciences
―
SVP of Finance & CFO
―
―
List of latest transactions for each holding click on a transaction to see Edward Myles's performance on stock
You May Also Like
Edward Myles insider profile FAQ
What is the percentage of profitable transactions made by Edward Myles?
The percentage of profitable transactions made by Edward Myles is ―.
What is the average return per transaction made by Edward Myles?
The average return per transaction made by Edward Myles is ―.
What stocks does Edward Myles hold?
Edward Myles holds: OCAT, AMAG, SRRK, PBIO stocks.
What was Edward Myles’s latest transaction?
Edward Myles latest transaction was an Uninformative Buy of ―.
What was Edward Myles's most profitable transaction?
Edward Myles’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Edward Myles's role in Ocata Therapeutics?
Edward Myles's role in Ocata Therapeutics is CFO and EVP of Corp. Dev..
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.